New and updated preclinical and clinical data presented by biopharma firms at the European Hematology Association's Annual Congress, including: ADC, Agios, Alx, Apellis, Aprea, Aptose, Astrazeneca, Autolus, Beigene, Bluebird, Constellation, Crispr, Editas, Forma, Imago, Imara, Geron, Keros, Kiadis, Omeros, Oryzon, Principia, Sierra Oncology, Takeda, TG, Tolero, Vertex, X4.